Syrs investor relations

Author: krzj

August undefined, 2024

WebSYRS will report Q1 earnings on 08/08/2024 Actual Analyst Range Consensus 3 0 -3 -5 More Overview Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive... WebMoved Permanently. The document has moved here.

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings …

WebMar 6, 2024 · This call is being webcast live on the Investors and Media section of Syros’ website […] Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call Transcript March 2, 2024 Operator: Good ... WebHeadquarters. 35 CambridgePark Drive 4th Floor Cambridge, MA 02140 Tel: (617) 744-1340 bloods post gastric band

Syros and Tyme Technologies Announce Stockholder Approval

WebDec 13, 2024 · The image below, which you can click on for greater detail, shows that at September 2024 Syros Pharmaceuticals had debt of US$40.1m, up from US$19.7m in one year. However, it does have US$145.6m ... WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ … WebApr 7, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of … freed ballroom shoes

Contacts :: Syros Pharmaceuticals, Inc. (SYRS)

SYRS - Syros Pharmaceuticals Inc Stock Price Quote

Web83 rows · Get the latest insider transactions for Syros Pharmaceuticals, Inc. (SYRS). Find out the total of insider shares held, purchased and sold. WebDirector of Corporate Communications & Investor Relations [email protected]. Stern Investor Relations, Inc. Hannah Deresiewicz [email protected]. Transfer Agent. Computershare Trust Company, N.A. Auditor. Ernst & Young LLP 200 Clarendon Street Boston, MA 02116 T: 617-266-2000 blood sport to your eternityWebMar 24, 2024 · Get the latest Syros Pharmaceuticals, Inc SYRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... As an investor, you want to buy stocks with the highest probability of ... free db2 client for windows

"WebOct 18, 2024 · About Syros Pharmaceuticals, Inc. 35 CAMBRIDGEPARK DRIVE 4TH FLOOR, CAMBRIDGE, Massachusetts, 2140, United States +1 617 744-1340 … " - Syrs investor relations

Syrs investor relations

Syros Reports Second Quarter 2024 Financial ... - Investor Relations

WebBased on analysts offering 12 month price targets for SYRS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . WebAug 9, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter ended June 30, 2024 and provided a corporate update. ... Stern Investor Relations, Inc. 212-362-1200 …

Did you know?

WebApr 6, 2024 · Get Syros Pharmaceuticals Inc (SYRS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebOct 14, 2024 · Find the latest SEC Filings data for Syros Pharmaceuticals, Inc. Common Stock (SYRS) at Nasdaq.com. Syros Pharmaceuticals, Inc. Common Stock (SYRS) SEC …

WebMar 2, 2024 · Investor Relations :: Syros Pharmaceuticals, Inc. (SYRS) Syros is redefining the power of small molecules to control gene expression with the aim of providing a … Syros to Participate in Upcoming Investor Conferences in March . Feb 23, 2024. … 2024 BIO CEO & Investor Conference. Feb 6, 2024 • 3:00pm PDT . 35th Annual J.P. … Do you want to load external content supplied by QMod Stock Tools? Yes We respect your privacy. We do not sell, rent, or loan any information to any third … Date Form Description PDF XBRL Pages; 04/06/23: S-3: Registration statement for … © 2024 Syros Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Terms of … CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands. 12 … 2024 Annual Report. 2024 Annual Report. 2024 Annual Report Gerald brings more than 20 years of senior leadership and legal experience in the … WebMar 3, 2024 · Review the current Syros Pharmaceuticals Inc (SYRS:XNAS) dividend yield and history to decide if ATUS stock is the best investment for you. ... Investor Relations Syros Pharmaceuticals Inc SYRS ...

WebDec 16, 2024 · What does smart money think about Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)? At Q3's end, a total of 9 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of ... WebMar 2, 2024 · Syros Pharmaceuticals, Inc. ( NASDAQ: SYRS) Q4 2024 Earnings Conference Call March 2, 2024 8:30 AM ET Company Participants Karen Hunady - Director-Investor …

WebApr 12, 2024 · How much institutional selling is happening at Syros Pharmaceuticals? Institutional investors have sold a total of 22,154,450 shares in the last 24 months. This volume of shares sold represents approximately $390.15M in transactions. This page (NASDAQ:SYRS) was last updated on 4/3/2024 by MarketBeat.com Staff.

WebFeb 24, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS News Morningstar Rating Rating as of Feb 24, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... bloods post anaphylaxisWebMar 7, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Chart Morningstar Rating Rating as of Mar 7, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... freed ballet shoesWebNov 14, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Karen Hunady - Director-Corporate Communications & Investor Relations bloodsport trailer